These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19618291)

  • 1. Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cells.
    Di JM; Pang J; Sun QP; Zhang Y; Fang YQ; Liu XP; Zhou JH; Ruan XX; Gao X
    Mol Biol Rep; 2010 Apr; 37(4):1849-55. PubMed ID: 19618291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells.
    Di JM; Pang J; Pu XY; Zhang Y; Liu XP; Fang YQ; Ruan XX; Gao X
    Cancer Genet Cytogenet; 2009 Jul; 192(2):60-7. PubMed ID: 19596255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
    Arunkumar N; Liu C; Hang H; Song W
    Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
    Ilvesaro JM; Merrell MA; Swain TM; Davidson J; Zayzafoon M; Harris KW; Selander KS
    Prostate; 2007 May; 67(7):774-81. PubMed ID: 17373717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells.
    Min R; Siyi L; Wenjun Y; Shengwen L; Ow A; Lizheng W; Chenping Z
    Cancer Sci; 2012 Nov; 103(11):1938-45. PubMed ID: 22853846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of TLR9 in esophageal cancer.
    Zhang Y; Wang Q; Ma A; Li Y; Li R; Wang Y
    Oncol Rep; 2014 May; 31(5):2298-304. PubMed ID: 24647486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
    Assaf A; Esteves H; Curnow SJ; Browning MJ
    Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG oligodeoxynucleotides induce IL-8 expression in CD34+ cells via mitogen-activated protein kinase-dependent and NF-kappaB-independent pathways.
    Kim JM; Kim NI; Oh YK; Kim YJ; Youn J; Ahn MJ
    Int Immunol; 2005 Dec; 17(12):1525-31. PubMed ID: 16263754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturated fatty acids up-regulate COX-2 expression in prostate epithelial cells via toll-like receptor 4/NF-κB signaling.
    Liu J; Hu S; Cui Y; Sun MK; Xie F; Zhang Q; Jin J
    Inflammation; 2014 Apr; 37(2):467-77. PubMed ID: 24221358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
    Fernández-Martínez AB; Collado B; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Mol Cell Endocrinol; 2007 May; 270(1-2):8-16. PubMed ID: 17434257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
    Meng W; Yamazaki T; Nishida Y; Hanagata N
    BMC Biotechnol; 2011 Sep; 11():88. PubMed ID: 21943407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells.
    Zhang J; Zhu QL; Huang P; Yu Q; Wang ZH; Cooper PR; Smith AJ; He W
    Int Endod J; 2013 Jul; 46(7):666-74. PubMed ID: 23331101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells.
    Wen X; Chao C; Ives K; Hellmich MR
    BMC Mol Biol; 2011 Jul; 12():29. PubMed ID: 21745389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
    Xu H; An H; Yu Y; Zhang M; Qi R; Cao X
    J Biol Chem; 2003 Sep; 278(38):36334-40. PubMed ID: 12867418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression.
    Lim EJ; Lee SH; Lee JG; Kim JR; Yun SS; Baek SH; Lee C
    Exp Mol Med; 2007 Apr; 39(2):239-45. PubMed ID: 17464186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis.
    Amcheslavsky A; Zou W; Bar-Shavit Z
    J Biol Chem; 2004 Dec; 279(52):54039-45. PubMed ID: 15485822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.